Immune cell therapy shows promise for tough leukemia cases
Disease control
Completed
This early-stage trial tested whether a special type of immune cell from donors, called natural killer (NK) cells, is safe for people with acute myeloid leukemia (AML) that has returned or not responded to treatment. Nineteen patients received the cells to see the highest safe do…
Phase: PHASE1 • Sponsor: Sumithira Vasu • Aim: Disease control
Last updated May 01, 2026 15:57 UTC